Juan Abundes
Soma Investor

Before joining Soma, Juan worked in venture at both Manchesterstory Group focusing across stages and at Impact Venture Capital leading early stage investments and portfolio management in both the US and abroad.

 

On the operations side, Juan was an R&D project lead at Genentech for influenza in oncology research. He helped co-develop new strains of the influenza vaccine and the G36 molecule to help treat age-related diseases.

 

He was also a Project Manager for Tylenol and other OTC drugs R&D at Johnson&Johnson helping re-engineer Tylenol in 2014 to what is in market today.

 

Juan studied Biochemistry and Data Science & Bioinformatics. He received his MBA at University of the Pacific.